跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 22 条关于
“Aukelso”
全部
22
临床试验
0
药物
1
机构
3
资讯
18
前天
Canada Approves Multiple Denosumab and Ustekinumab Biosimilars as Global Competition Intensifies
12个月前
Biocon Biologics Targets $7 Billion Global Biosimilar Market with FDA-Approved Denosumab Products
去年
Akeso Biopharma Secures $250 Million to Advance Global Clinical Trials
去年
Akeso Completes Patient Enrollment in Phase III Trial Comparing Ivonescimab for First-Line Squamous NSCLC Treatment
2年前
Akeso Highlights Bispecific Antibody Data at ESMO 2024, Demonstrating Promising Results in Multiple Cancers
去年
Akeso Initiates Phase 3 Trial of Ivonescimab Plus Ligufalimab in Head and Neck Cancer
6个月前
INOVIO and Akeso Partner to Test Novel DNA-Bispecific Antibody Combination for Glioblastoma Treatment
2年前
Akeso Initiates Phase III Trial of Cadonilimab Bispecific Antibody for PD-L1 Negative NSCLC
2年前
Akeso's Ivonescimab Demonstrates Superiority Over Pembrolizumab in Lung Cancer Trial
去年
Akeso's Ivonescimab Enrolls First Patient in Phase III Biliary Tract Cancer Trial
第 1 页,共 2 页
上一页
下一页